Zura Bio Limited Class A Ordinary Shares (ZURA) Stock
NASDAQ · ZURA
4.46
Fundamentals
Market cap
$427.40M
Price / Earnings ratio
-3.8x
Price / Sales ratio
N/A
Price / Book ratio
2.2x
Return on assets
-0.7%
Ex-Dividend date
N/A
Last payment date
N/A
Dividend amount
$0.00
Dividend yield
0.0%
Debt / Equity ratio
N/A
Latest news
About Zura Bio Limited Class A Ordinary Shares
No description available.
SectorHealthcare
IndustryBiotechnology
Employees40
CEODr. Sandeep Chidambar Kulkarni M.D.
IPO DateSep 3, 2021
HeadquartersHenderson, NV
Key Executives
| Name | Title | Year Born |
|---|---|---|
| Dr. Sandeep Chidambar Kulkarni M.D. | Co-Founder, CEO & Director | 1981 |
| Ms. Kimberly Ann Davis J.D. | COO, Chief Legal Officer & Corporate Secretary | 1968 |
| Dr. Kiran Nistala MBBS, Ph.D. | Chief Medical Officer & Head of Development | 1973 |
| Ms. Marlyn Mathew | VP of Finance & Accounting and Principal Financial & Accounting Officer | 1984 |
| Dr. Gary Whale Ph.D. | Chief Technology Officer | 1974 |
| Ms. Theresa Lowry | Chief Human Resources Officer | 1974 |
| Mr. Muzammil Mustufa | Chief Business Officer | — |
Fundamentals
Valuation
Market cap$427.40M
Price-to-sales ratioN/A
Price-to-book value2.22
Price-earnings ratio-3.80
Return on Equity-77.00%
Return on SalesN/A
Return on AssetsN/A
PEG ratioN/A
Earnings Per Share
Earnings Per Share$-1.13
Income Statement
Average volume1,746,003
EBITDA$-74.54M
1 year high (52w)$7.44
1 year low (52w)$1.88
Dividend
Ex dividend dateN/A
Dividend amount$0.00
Dividend yield0.00%
Last payment dateN/A
Dividend yield (TTM)N/A
Next earnings reportN/A
Solvency
Debt-to-equity ratioN/A



